E-LIB Suche - Ergebnisse für: Makarenko, Tatiana V.

1

Capabilities of Business Analysis in Developing Data-Driven..:

, In: Smart Green Innovations in Industry 4.0 for Climate Change Risk Management; Environmental Footprints and Eco-design of Products and Processes,

Makarenko, Elena N. ; Chernysheva, Yulia G. ; Polyakova, Irina A... - p. 35-45 , 2023

Link: https://doi.org/10.1007/..

2

Analysis of Business Data and Cybersecurity as New Areas of..:

, In: Technological Trends in the AI Economy; Smart Innovation, Systems and Technologies,

Makarenko, Elena N. ; Makarenko, Tatiana V. ; Chernysheva, Yulia G... - p. 41-47 , 2023

Link: https://doi.org/10.1007/..

3

Development of the Audit Services Market in Russia:

, In: Strategies and Trends in Organizational and Project Management; Lecture Notes in Networks and Systems,

Makarenko, Elena N. ; Labyntsev, Nikolay T. ; Andreeva, Natalia A.. - p. 613-624 , 2022

Link: https://doi.org/10.1007/..

4

Practical Recommendations for Monitoring and Control of the..:

, In: Models of Modern Information Economy,

Khakhonova, Natalia N. ; Makarenko, Elena N. ; Makarenko, Tatiana V.. - p. 323-331 , 2018

Link: https://doi.org/10.1108/..

5

Reactions of 1-amino-2-nitroguanidine with 3-nitroacrylates:

Ozerova, Olga Yu. ; Efimova, Tatiana P. ; Novikova, Tamara A...
Mendeleev Communications. 34 (2024) 2 - p. 265-267 , 2024

Link: https://doi.org/10.1016/..

6

Features of the reaction of 1-amino-2-nitroguanidine with i..:

Efimova, Tatiana P. ; Ivanova, Mariya P. ; Novikova, Tamara А..
Chemistry of Heterocyclic Compounds. 57 (2021) 10 - p. 1002-1006 , 2021

Link: https://doi.org/10.1007/..

7

PKPD Modeling and Simulations to Support Biosimilar Develop..:

Petrov, Aleksandr V. ; Zinnatulina, Bella R. ; Drai, Roman V....
Clinical Pharmacology in Drug Development. 11 (2022) 12 - p. 1457-1466 , 2022

Link: https://doi.org/10.1002/..

8

Clinical Pharmacology of Insulin Aspart Biosimilar GP40071:..:

Drai, Roman V. ; Karonova, Tatiana L. ; Mayorov, Alexander Y....
Clinical Pharmacology in Drug Development. 11 (2022) 8 - p. 922-929 , 2022

Link: https://doi.org/10.1002/..

9

Characterization of the mitochondrial genome of the MAX1 ty..:

Makarenko, Maksim S. ; Usatov, Alexander V. ; Tatarinova, Tatiana V....
BMC Plant Biology. 19 (2019) S1 - p. , 2019

Link: https://doi.org/10.1186/..

10

Organization Features of the Mitochondrial Genome of Sunflo..:

Makarenko, Maksim S. ; Usatov, Alexander V. ; Tatarinova, Tatiana V....
Plants. 8 (2019) 11 - p. 439 , 2019

Link: https://doi.org/10.3390/..

11

Phosphinohydrazines and phosphinohydrazides M(–N(R)–N(R)–PP..:

Fedotova, Yana V. ; Kornev, Alexander N. ; Sushev, Vyacheslav V....
Journal of Organometallic Chemistry. 689 (2004) 19 - p. 3060-3074 , 2004

Link: https://doi.org/10.1016/..

12

Organization Features of the Mitochondrial Genome of Sunflo..:

Makarenko, Maksim S ; Usatov, Alexander V ; Tatarinova, Tatiana V...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918226/. , 2019

Link: http://www.ncbi.nlm.nih...

13

Использование информационно-коммуникативных технологий в ДО..:

Кислова Татьяна Викторовна ; Tatiana V. Kislova ; Конева Наталья Владимировна...
info:eu-repo/semantics/altIdentifier/isbn/978-5-6049227-1-2. , 2022

Link: https://interactive-plus..

14

Evaluation of biosimilarity of RinGlar® (GEROPHARM LLC, Rus..:

Alexander Y. Mayorov ; Roman V. Drai ; Tatiana L. Karonova...
https://www.dia-endojournals.ru/jour/article/view/10095. , 2020

Link: https://doi.org/10.14341..

15

Organization Features of the Mitochondrial Genome of Sunflo..:

Maksim S. Makarenko ; Alexander V. Usatov ; Tatiana V. Tatarinova...
https://www.mdpi.com/2223-7747/8/11/439. , 2019

Link: https://doi.org/10.3390/..